Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...

Antibody-based therapies are used to treat numerous diseases, from cancer to rheumatic disorders and multiple sclerosis.

Common genetic variants can prevent antibody therapies from binding their targets, reducing treatment effectiveness. The ...

Strategic divestiture MindWalk closed the sale of its Netherlands operations, generating net proceeds of $14.3 million. The divestiture allows the Company to allocate resources toward its BioNative AI ...

Antigen spreading was evaluated in a subset of Phase 2 patients to assess the ability of ELI-002 7P to broaden immune responses to personalized tumor neoantigens not present in the targeted ...

The genome differs from person to person in thousands of positions. In some cases, this means that proteins have a different ...

Event Title: MindWalk Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2026 https://events.q4inc.com/attendee/410261259 ...